SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
November 25, 1997
Mallinckrodt Inc.
(Exact name of registrant as specified in its charter)
New York 1-483 36-1263901
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
675 McDonnell Boulevard, St. Louis, MO 63134
(Address of principal executive offices) (ZIP Code)
Registrant's telephone number, (314) 654-2000
including area code
PAGE
<PAGE>
Item 5. Other Events
A press release was issued November 25, 1997. The relevant portion
of the text of that release was as follows:
(*) Indicates registered trademark
MALLINCKRODT WINS STAY OF INJUNCTION IN WarmTouch(*) BLANKET CASE
ST. LOUIS, Mo., November 25, 1997 The U. S. Court of Appeals for
the federal circuit in Washington, D. C., has ruled that Mallinckrodt
Inc. (NYSE:MKG) can continue to sell its WarmTouch(*) patient warming
blankets in the United States until the company's appeal in a patent
infringement case is decided.
In September, Augustine Medical Inc., another manufacturer of
patient warming systems, won a jury verdict of patent infringement
against Mallinckrodt. At that time, the U. S. District Court in
Minneapolis enjoined Mallinckrodt from selling blankets in the United
States. However, that injunction was temporarily stayed by the
federal court of appeals, so Mallinckrodt has been able to sell
blankets. The court's latest action allows Mallinckrodt to continue
selling until a decision is made on the appeal.
"The court's action will allow us to continue serving our
customers and to ensure that service to patients will not be
disrupted.," said Donal Quinn, vice president of Mallinckrodt's
Critical Care Division. "We are eager for our appeal to be heard.
We believe we have strong arguments that our blankets do not infringe
Augustine's patents."
WarmTouch(*) blankets connect to blowers that fill the blankets
with warm air. This creates a warming system that helps control
patient body temperatures. Medical research has demonstrated patient
benefits from such warming, including improved post-surgical recovery
time.
Mallinckrodt Inc. serves healthcare and specialty chemicals
markets worldwide. The company has four major businesses
pharmaceuticals, diagnostic imaging, respiratory care and specialty
chemicals. The St. Louis, Missouri-based company, with fiscal 1997
net adjusted sales of $1.9 billion, operates in more than 100
countries. The Mallinckrodt web site address is
(www.mallinckrodt.com).
# # #
Mallinckrodt Inc.
ROGER A. KELLER
Vice President, Secretary
and General Counsel
DATE: November 26, 1997
